D. Avenin

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study

Thierry André, Christophe Tournigand, Olivier Rosmorduc et al. · Annals of Oncology · 2004 · 383 citations · Full text

Medicine, Oncology, Pharmacology +13

Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients

Anne Fajac, Joseph Gligorov, Keyvan Rezaï et al. · British Journal of Cancer · 2010 · 38 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma

Thierry André, Jean Pierre Lotz, Carole Bouleuc et al. · Annals of Oncology · 1996 · 34 citations

Medicine, Oncology, Pharmacology +11

Influence of ABCB1 polymorphisms and docetaxel pharmacokinetics on pathological response to neoadjuvant chemotherapy in breast cancer patients

Pierre Lévy, Joseph Gligorov, Martine Antoine et al. · Breast Cancer Research and Treatment · 2013 · 20 citations

Medicine, Oncology, Pharmacokinetics +17

A phase II study of gemcitabine and oxaliplatin (gemox) in advanced biliary adenocarcinoma (ABA). Preliminary results

Thierry André, Christophe Louvet, Pascal Artru et al. · European Journal of Cancer · 2001 · 12 citations

Medicine, Oncology, Pharmacology +13